Wilms Tumor

• 

  Subject Areas on Research

  • A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors. 
  • An exploratory study of environmental and medical factors potentially related to childhood cancer. 
  • Array CGH profiling of favourable histology Wilms tumours reveals novel gains and losses associated with relapse. 
  • B7-H1 expression in Wilms tumor: correlation with tumor biology and disease recurrence. 
  • B7-h1 as a biomarker for therapy failure in patients with favorable histology Wilms tumor. 
  • Biomarkers for Wilms Tumor: A Systematic Review. 
  • Characterization of renal neoplasms with monoclonal antibodies to leukocyte differentiation antigens. 
  • Childhood cancer and occupational radiation exposure in parents. 
  • Comparing oncologic outcomes after minimally invasive and open surgery for pediatric neuroblastoma and Wilms tumor. 
  • Current concepts in the biology and management of Wilms tumor. 
  • Current concepts. Cancer in children. 
  • Decreased E-cadherin expression correlates with higher stage of Wilms' tumors. 
  • Development and Validation of a Prediction Model for Kidney Failure in Long-Term Survivors of Childhood Cancer. 
  • Developmental cystic renal neoplasms in children. Diagnostic imaging characteristics. 
  • Diagnosis and management of Wilms' tumor. 
  • Editorial comment. 
  • Editorial comment. 
  • Fine mapping of Wilms' tumors with 16q loss of heterozygosity localizes the putative tumor suppressor gene to a region of 6.7 megabases. 
  • High dose chemotherapy with autologous peripheral blood progenitor cell transplantation in an anephric child with multiply recurrent Wilms tumor. 
  • Immune expression in children with Wilms tumor: a pilot study. 
  • Immunotherapeutic targeting of Wilms' tumor protein. 
  • Incidence and management of pleural effusions in patients with Wilms tumor: A Pediatric Surgical Oncology Research Collaborative study. 
  • Increased microvascular density predicts relapse in Wilms' tumor. 
  • Initial testing (stage 1) of the kinesin spindle protein inhibitor ispinesib by the pediatric preclinical testing program. 
  • Initial testing of cisplatin by the pediatric preclinical testing program. 
  • Late Health Outcomes Among Survivors of Wilms Tumor Diagnosed Over Three Decades: A Report From the Childhood Cancer Survivor Study. 
  • Linkage of familial Wilms' tumor predisposition to chromosome 19 and a two-locus model for the etiology of familial tumors. 
  • Management of solid tumors in children. 
  • Megestrol acetate in pediatric oncology patients may lead to severe, symptomatic adrenal suppression. 
  • Minimally invasive surgery for pediatric renal tumors: A systematic review by the APSA Cancer Committee. 
  • Morphological survey of teleost organs important in carcinogenesis with attention to fixation. 
  • Multimodal therapy for stage IV adult Wilms tumor. 
  • Nephron sparing surgery and surgical management of intravascular extension of Wilms tumor. 
  • Nephron-sparing surgery for Wilms tumor: A systematic review. 
  • Occurrence of Henoch-Schönlein purpura in a child with Wilms' tumor. 
  • Pediatric radiation oncology. 
  • Pediatric solid tumors and associated cancer predisposition syndromes: Workup, management, and surveillance. A summary from the APSA Cancer Committee. 
  • Pigment epithelium-derived factor targets endothelial and epithelial cells in Wilms' tumor. 
  • Pleural malignant mesothelioma following Wilms' tumor. 
  • Psychological, educational, and social late effects in adolescent survivors of Wilms tumor: A report from the Childhood Cancer Survivor Study. 
  • Reduction in Late Mortality among 5-Year Survivors of Childhood Cancer. 
  • Risk factors for Wilms tumor. Report from the National Wilms Tumor Study. 
  • Secretion of a large molecular-weight form of insulin-like growth factor by a primary renal tumor. 
  • Severe encephalopathy associated with ifosfamide administration in two children with metastatic tumors. 
  • Severe subcutaneous hemiatrophy following treatment of Wilms' tumor: CT demonstration. 
  • The isolation and characterization of a novel cDNA demonstrating an altered mRNA level in nontumorigenic Wilms' microcell hybrid cells. 
  • Twenty-five year follow-up of childhood Wilms tumor: a report from the Childhood Cancer Survivor Study. 
  • Urologic surgery. 
  • Use of nephron sparing surgery and impact on survival in children with Wilms tumor: a SEER analysis. 
  • Vascular control for resection of suprahepatic intracaval Wilms' tumor: technical considerations. 
  • Wilms Tumor After Orthotopic Liver Transplant in a Patient With Alagille Syndrome. 
  • Wilms tumor imaging: patient costs and protocol compliance. 
  • Wilms' tumor and paternal occupation. 
  • Wilms' tumor growth is suppressed by antiangiogenic pigment epithelium-derived factor in a xenograft model. 
• 

  Keywords of People

  • Hogan, Brigid L. M., Research Professor of Cell Biology, Cell Biology
  • Routh, Jonathan Charles, Paul H. Sherman, M.D. Distinguished Associate Professor of Surgery, Pediatrics